Whistleblower disclosures to the General Pharmaceutical Council (GPhC) jumped by 208 percent over the past year, underscoring growing concerns about breaches of professional standards and fitness to practise issues within pharmacy teams.
According to the GPhC report, the regulator received 46 disclosures in 2024, up from 15 in 2023. Many of these raised questions about unsafe dispensing practices, inadequate supervision and failures to escalate concerns about colleagues’ fitness to practise.
The GPhC said the increase reflects greater confidence among registrants and support staff in coming forward, as well as its strengthened whistleblowing framework. A spokesperson for the regulator stressed that timely reporting of concerns is essential to protect the public and uphold the integrity of the profession.
The GPhC continues to refine its processes to ensure every disclosure is assessed by fitness to practise specialists and that appropriate regulatory action is taken where necessary.
Disclaimer: The accuracy and information of news stories published on this website is accurate on the date of publishing. We endeavour to update stories if information change. You can contact us with change and update requests. Where possible, we will link to sources. Content on this website is for guidance purposes only. We cannot accept any responsibility or liability whatsoever for any action taken, or not taken. You should seek the appropriate legal advice having regard to your own particular circumstances.
Restoration Courses
Courses suitable for any health and social care practitioner who is considering making an application for restoration back onto the register.
Insight & Remediation
Courses that are suitable for any healthcare practitioner who is facing an investigation or hearing at work or before their regulatory body.
Probity, Ethics & Professionalism
Courses designed for those facing a complaint involving in part or in whole honesty, integrity and /or professionalism.
Recent Comments